ストックスクリーナーアプリを入手
527.00
0.63%
-3.35
プレマーケット:
529.80
2.80
+0.53%
前日終値:
$530.35
開ける：
$528.36
24時間の取引高:
504.82K
Relative Volume:
1.15
時価総額：
$23.10B
収益：
$3.18B
当期純損益:
$1.33B
株価収益率:
18.89
EPS:
27.9001
ネットキャッシュフロー:
$1.04B
1週間 パフォーマンス:
-1.09%
1か月 パフォーマンス:
+9.67%
6か月 パフォーマンス:
+26.21%
1年 パフォーマンス:
+65.28%
1日の値動き範囲:
$524.30
$533.73
1週間の範囲:
$523.50
$543.37
52週間の値動き範囲:
$266.98
$548.12
United Therapeutics Corp Stock (UTHR) Company Profile
名前
United Therapeutics Corp
セクター
電話
(301) 608-9292
住所
1000 SPRING ST, SILVER SPRING, MD
Compare UTHR vs TAK, ZTS, HLN, TEVA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
527.00 | 23.10B | 3.18B | 1.33B | 1.04B | 27.90 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 57.21B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.99 | 48.96B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.44 | 34.29B | 17.41B | 1.43B | 1.00B | 1.2182 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-20 | 開始されました | Wells Fargo | Underweight |
| 2025-09-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-06-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-04-21 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-07-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | アップグレード | Goldman | Sell → Neutral |
| 2024-02-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2022-12-06 | 開始されました | UBS | Buy |
| 2022-12-05 | 開始されました | Goldman | Sell |
| 2022-10-11 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-20 | 繰り返されました | BofA Securities | Underperform |
| 2022-09-19 | 再開されました | Wedbush | Outperform |
| 2022-02-11 | 開始されました | BTIG Research | Neutral |
| 2021-07-14 | アップグレード | Argus | Hold → Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-02-01 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-06-25 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-03-10 | アップグレード | Jefferies | Hold → Buy |
| 2020-02-27 | アップグレード | Cowen | Market Perform → Outperform |
| 2020-01-31 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-12-03 | 開始されました | BofA/Merrill | Underperform |
| 2019-08-01 | アップグレード | Jefferies | Underperform → Hold |
| 2019-08-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | アップグレード | UBS | Sell → Neutral |
| 2019-05-09 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | アップグレード | Standpoint Research | Hold → Buy |
| 2018-08-08 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | 繰り返されました | Barclays | Underweight |
| 2018-01-18 | 再開されました | Credit Suisse | Underperform |
| 2017-12-27 | 繰り返されました | Wedbush | Outperform |
| 2017-04-27 | 繰り返されました | Wedbush | Outperform |
| 2017-03-30 | 開始されました | UBS | Sell |
| 2017-03-16 | 開始されました | Credit Suisse | Underperform |
すべてを表示
United Therapeutics Corp (UTHR) 最新ニュース
Idiopathic Pulmonary Fibrosis Clinical Trial Pipeline Expands as 80+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart
Paul Mahon Sells 8,300 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics CEO Rothblatt sells $5m in UTHR stock - Investing.com
Biotech Stocks Worth WatchingMarch 18th - MarketBeat
MannKind: Strategic Uncertainty Follows United Therapeutics' Pivot (Rating Downgrade) - Seeking Alpha
Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock - MarketBeat
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 9,500 Shares - TradingView
United Therapeutics Corporation $UTHR Holdings Lifted by L2 Asset Management LLC - MarketBeat
Assessing United Therapeutics (UTHR) Valuation After TETON-2 Tyvaso Data And New US$2b Buyback Program - simplywall.st
Rothblatt of United Therapeutics sells $5.1 million in UTHR stock - Investing.com
Insider Sell: Judy Olian Sells Shares of United Therapeutics Cor - GuruFocus
Judy Olian sells 400 UTHR shares across March transactions (UTHR) - Stock Titan
United Therapeutics CEO Martine A. Rothblatt Executes Stock Sales - TradingView
United Therapeutics (UTHR) director sells 200 shares under 10b5-1 plan - Stock Titan
United Therapeutics (UTHR) CEO pre-planned option exercise and 9,500-share sale - Stock Titan
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 8,984 Shares - MarketBeat
United Therapeutics (NASDAQ:UTHR) CEO Sells $276,054.84 in Stock - MarketBeat
Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It - MSN
Rothblatt, United Therapeutics CEO, sells $5.1m in UTHR stock - Investing.com
United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan
United Therapeutics stock surges 32% in 6 months: Here's why - MSN
United Therapeutics Stock Surges 32% in 6 Months: Here's Why - Yahoo Finance
Van ECK Associates Corp Purchases 29,297 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Korea Investment CORP Has $5.90 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Shares Jump 32% Over Six Months: The Reasons Explained - Bitget
UBS raises United Therapeutics stock price target to $705 on catalysts - Investing.com Nigeria
Cantor Fitzgerald raises United Therapeutics stock price target to $625 - Investing.com Nigeria
Cantor Fitzgerald raises United Therapeutics stock price target to $625 By Investing.com - Investing.com India
Inhaled IPF drug from United Therapeutics slows lung scarring in trial - Stock Titan
United Therapeutics (UTHR) CEO trades shares under 10b5-1 stock plan - Stock Titan
United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade) - Seeking Alpha
Capital Fund Management S.A. Purchases 20,410 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics Corp (UTHR) Shares Up 3.04% on Mar 10 - GuruFocus
United Therapeutics (NASDAQ:UTHR) Sets New 1-Year HighHere's What Happened - MarketBeat
United Therapeutics stock hits all-time high at 537.83 USD - Investing.com
United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains? - Yahoo Finance
Grantham Mayo Van Otterloo & Co. LLC Acquires 6,079 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Insider Sell: Judy Olian Sells 200 Shares of United Therapeutics Corp (UTHR) - GuruFocus
United Therapeutics Corp (UTHR) Shares Up 8.91% on Mar 9 - GuruFocus
United Therapeutics Launches $1.5 Billion Accelerated Share Repurchases With Citi Under $2 Billion Buyback - TradingView
United Therapeutics CEO Martine A. Rothblatt Sells 9,500 Shares - TradingView
United Therapeutics stock jumps 9% on $2B buyback program - Investing.com
United Therapeutics at Leerink Conference: Advancing Pulmonary Treatments - Investing.com
United Therapeutics stock buyback signals franchise confidence, TD Cowen says - Investing.com Nigeria
United Therapeutics (NASDAQ:UTHR) Shares Gap UpStill a Buy? - MarketBeat
United Therapeutics authorizes $2 billion buyback program - Investing.com
United Therapeutics sends $1.5B upfront for stock, $500M left - Stock Titan
First Trust Advisors LP Trims Stake in United Therapeutics Corporation $UTHR - MarketBeat
Rhenman & Partners Asset Management AB Buys Shares of 8,000 United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corp (UTHR) 財務データ
収益
当期純利益
現金流量
EPS
1.75%
2.39%
大文字化:
|
ボリューム (24 時間):